European research project provides further research evidence about Atopic Dermatitis and Psoriasis, the two most common inflammatory skin diseases which aﬀect more than 300 million people worldwide. Both conditions are a huge burden to patients and families, care-givers and healthcare systems in general: BIOMAP releases animated clip. The IMI 2 project BIOMAP has now released an animated clip illustrating the project work to alleviate the burden and consequences of Atopic Dermatitis and Psoriasis for people living with the diseases. The short animation aims to show the project’s approach and goals in an easy-to-understand format to inform interested non-professionals about how BIOMAP is about to increase the knowledge on atopic dermatitis and psoriasis. Since the project launch in 2019, more than 30 leading international players from academia, pharma industry and civil society have joined forces to improve direct disease management by combining clinical, genetic and epidemiological expertise with modern molecular analysis techniques and newly-developed tools in bioinformatics. The clip moreover illustrates the project’s pathway towards providing further research evidence about both diseases to alleviate the burden and consequences for people living with the conditions by addressing three unmet needs, which will have a broad impact on disease management, patient-directed care strategies and future trial designs:
- The identification of major determinants of manifestation, progression and comorbidity development
- An improved understanding of overlapping or unique disease mechanisms, associated signatures and their importance in patient subpopulations
- The identification of markers capable of assessing disease-related individual patient trajectories and response to different therapies.